Cinaciguat Uses, Dosage, Side Effects and more

Cinaciguat is under investigation in clinical trial NCT01067859 (A Phase Iib Study to Investigate the Efficacy and Tolerability of Lower Doses Cinaciguat (25 ΜG/h, 10 ΜG/h) Given Intravenously to Patients With Acute Decompensated Chronic Congestive Heart Failure (ADHF)).

Trade Name Cinaciguat
Generic Cinaciguat
Cinaciguat Other Names Cinaciguat
Type
Formula C36H39NO5
Weight Average: 565.71
Monoisotopic: 565.28282336
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: January 7, 2025 at 1:49 am

Innovators Monograph

*** Taking medicines without doctor's advice can cause long-term problems.
Share